
|
Geoffrey B. Davis
Partner
|
|


|
|
Geoff has extensive experience representing biotechnology, biomedical, medical device and pharmaceutical companies. Geoff’s work includes numerous corporate partnering and licensing transactions for major pharmaceutical and medical device companies, as well as for public and private biotechnology companies and major medical centers. He has also worked extensively on public and private financings for biomedical companies of all sizes, ranging from newly organized companies to established industry leaders, on behalf of both companies and their investment bankers. In addition to his life sciences work, Geoff has broad experience representing other technology-based companies, in areas such as e-commerce, digital media, social networking and commercial and consumer electronics.
- Represented Pfizer Inc. in regard to multiple licensing and collaboration matters, including such transactions as:
- Pfizer’s establishment of The Global Centers for Therapeutic Innovation, partnering scientists from academic research centers around the world with Pfizer’s leading drug development teams in an effort to accelerate drug development initiatives, and
- Pfizer’s collaboration with Ensemble Discovery Corporation to discover, develop and commercialize novel compounds that are active against important therapeutic targets, particularly those involving protein-protein interactions
- Represented Wyeth in numerous licensing and collaboration deals, including transactions with Advanced Life Sciences, Santaris Pharma, Élan, Trubion, Progenics, AlphaVax, Pharmacopeia, Catalyst Biosciences, Elbion, Biotica Technology, Nautilus Biotech, Losan Pharma, and Exelixis
- Represented Wyeth’s Consumer Healthcare Division on licensing, supply and related deals for several of its largest product lines
- Represented Wyeth in its divestiture of a portfolio of 10 marketed products in Europe by means of an asset sale and purchase agreement, interim supply agreement, interim license agreement, interim distribution and promotion agreement and various ancillary agreements
- Represented Becton, Dickinson and Company in:
- BD’s $270 million sale of three distinct product groups: ophthalmic systems, surgical blades/scalpels, and critical care systems, to portfolio companies of RoundTable Healthcare Partners;
- BD’s acquisition of Accuri Cytometers, Inc.;
- BD’s $275 million acquisition of HandyLab, Inc.; as well as in multiple licensing and collaboration matters
- Represented StemCells, Inc. in its initial public offering and in more than 20 subsequent financings, as well as licensing and collaboration matters
- Represented Zalicus Inc., formerly known as CombinatoRx Inc., in its initial public offering and in several subsequent financings
- Represented numerous underwriters, including J.P. Morgan, Deutsche Bank and Goldman Sachs in initial public offerings and other public financings for biotech and medical device companies
Honors & Awards
- Chambers Global: The World's Leading Lawyers for Business (2008-2012)
- Chambers USA: America's Leading Lawyers for Business (2007-2011)
- PLC Which Lawyer? Yearbook: USA (2007, 2010 - 2011)
Professional & Civic Activities
- Geoff helped to found and serves on the Board of the Slater Technology Center, an independent state-sponsored non-profit corporation which has been instrumental in achieving over $50 million of government and private funding for more than 20 start-up biomedical companies in Rhode Island.
- Geoff is a former Chairman of the Board of Trinity Repertory Theater, Planned Parenthood of Rhode Island and the Herreshoff Marine Museum.
- He served as a reporter, editor and managing editor of Phoenix-Times Newspapers for six years between college and law school.
©1996-2012 Ropes & Gray LLP. All rights reserved.
|
|
Education
-
JD, cum laude, Harvard Law School, 1979
-
BA, cum laude, Yale University, 1970
Bar Admissions
- Massachusetts, 1980
- Rhode Island, 1979
Memberships & Affiliations
- American Bar Association
- Boston Bar Association
- Massachusetts Bar Association
- Rhode Island Bar Association
|
|